Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine if topical SB-275833 ointment, 1% is as safe and
effective as topical sodium fusidate ointment, 2% for the treatment of impetigo in adults and
children as young as 9 months of age.